Parsanathan R, Jain S
Metab Syndr Relat Disord. 2019; 18(1):10-30.
PMID: 31618136
PMC: 7041332.
DOI: 10.1089/met.2019.0073.
Duguez S, Duddy W, Johnston H, Laine J, Le Bihan M, Brown K
Cell Mol Life Sci. 2013; 70(12):2159-74.
PMID: 23344255
PMC: 11113779.
DOI: 10.1007/s00018-012-1248-2.
Dubowitz V
Postgrad Med J. 2011; 41(476):332-46.
PMID: 21313711
PMC: 2483018.
DOI: 10.1136/pgmj.41.476.332.
Richterich R, ROSIN S, Aebi U, Rossi E
Am J Hum Genet. 1963; 15(2):133-54.
PMID: 17948483
PMC: 1932227.
ROTTHAUWE H, ZURUKZOGLU-SKLAVOUNOU S, HAMMANN H
Klin Wochenschr. 1961; 39:1269-75.
PMID: 14494477
DOI: 10.1007/BF01481966.
[Creatine phosphokinase (CPK) of serum in myotonic dystrophy].
Kuhn E, STEHLIN H, Stein W
Klin Wochenschr. 1962; 40:744-5.
PMID: 14460324
DOI: 10.1007/BF01482416.
[ON THE LOCALIZATION OF CREATINE KINASE (CK) IN MITOCHONDRIA AND MICROSOMES IN HUMAN SKELETAL MUSCLES, MYOCARDIUM AND CEREBRAL CORTEX].
KLEINE T
Klin Wochenschr. 1965; 43:504-10.
PMID: 14304913
DOI: 10.1007/BF01486091.
[CLINICAL AND BIOCHEMICAL STUDIES IN MYOPATHIES. I. SERUM ENZYMES IN PROGRESSIVE MUSCULAR DYSTROPHY (TYPE I, II, IIIA)].
ROTTHAUWE H, Kowalewski S
Klin Wochenschr. 1965; 43:144-50.
PMID: 14258511
DOI: 10.1007/BF01484506.
CREATINE KINASE IN CEREBROSPINAL FLUID.
HERSCHKOWITZ N, Cumings J
J Neurol Neurosurg Psychiatry. 1964; 27:247-50.
PMID: 14175294
PMC: 495734.
DOI: 10.1136/jnnp.27.3.247.
SERUM ENZYME STUDIES IN MUSCLE DISEASE. III. SERUM CREATINE KINASE ACTIVITY IN RELATIVES OF PATIENTS WITH THE DUCHENNE TYPE OF MUSCULAR DYSTROPHY.
Pearce J, PENNINGTON R, Walton J
J Neurol Neurosurg Psychiatry. 1964; 27:181-5.
PMID: 14175282
PMC: 495722.
DOI: 10.1136/jnnp.27.3.181.
SERUM LEVELS OF CREATINE PHOSPHOKINASE.
Griffiths P
J Clin Pathol. 1964; 17:56-7.
PMID: 14100004
PMC: 480672.
DOI: 10.1136/jcp.17.1.56.
Serum enzyme changes in muscle disease and their relation to tissue change.
Hughes B
Proc R Soc Med. 1963; 56:179-82.
PMID: 13955533
PMC: 1897332.
X-chromosome mosaicism in females with muscular dystrophy.
Pearson C, Fowler W, Wright S
Proc Natl Acad Sci U S A. 1963; 50:24-31.
PMID: 13942246
PMC: 300648.
DOI: 10.1073/pnas.50.1.24.
[Serum creatine phosphokinase: determination and diagnostic significance].
COLOMBO J, Richterich R, Rossi E
Klin Wochenschr. 1962; 40:37-44.
PMID: 13880679
DOI: 10.1007/BF01483449.
A method for the detection of carriers of Duchenne muscular dystrophy--a preliminary report.
MONCKTON G, Marusyk H, Pehowich E
Am J Hum Genet. 1981; 33(6):978-86.
PMID: 7325161
PMC: 1685149.
The female carrier of Duchenne muscular dystrophy.
Dubowitz V
Br Med J (Clin Res Ed). 1982; 284(6327):1423-4.
PMID: 6805547
PMC: 1498325.
DOI: 10.1136/bmj.284.6327.1423.
Studies of the carrier state in the Duchenne type of muscular dystrophy. I. Effect of exercise on serum creatine kinase activity.
HUDGSON P, Gardner-Medwin D, PENNINGTON R, Walton J
J Neurol Neurosurg Psychiatry. 1967; 30(5):416-9.
PMID: 6062992
PMC: 496217.
DOI: 10.1136/jnnp.30.5.416.
[Progressive muscular dystrophy. VII. Detection of heterozygotes of Duehenne muscular dystrophy by determining serum creatine kinase with localized work load in anoxia].
Wiesmann U, Moser H, Richterich R, Rossi E
Klin Wochenschr. 1965; 43(19):1015-22.
PMID: 5881526
DOI: 10.1007/BF01746589.
[Discussion remarks on the work of C.M.Büsing, H. Heyck and G.G. Laudahn: "The detection of female transmitters of the Duchenne type progressive muscular dystrophy by means of discriminative analysis of various serum enzyme activities"].
BARTHELMAI W
Klin Wochenschr. 1970; 48(8):497.
PMID: 5519403
DOI: 10.1007/BF01485103.
[Diagnosis of female carriers of Duchenne's progressive muscular dystrophy using discriminative analysis of various serum enzyme activities].
Busing C, HEYCK H, LAUDAHN G
Klin Wochenschr. 1969; 47(20):1099-103.
PMID: 5381991
DOI: 10.1007/BF01496643.
